Epidemiologic studies have stated the progressive increase of bladder
tumors during the last decades. The aim of our review is to refer to f
actors implicated in bladder carcinogenesis (such as activated oncogen
es, growth factors and chromosomal aberrations) and to resistance to d
rug uptake (i.e., multidrug resistance gene and P-glycoprotein). The r
eview also provides information of diagnostic and prognostic significa
nce, based on DNA analysts of transitional cancer cells. In addition t
o cytometric data, alternative counterings for estimation of the S-pha
se fraction, useful in indicating the biologic behavior of bladder can
cer, are presented. Knowledge of such mechanisms results in a better a
pproach to the diagnosis, prognosis and prevention of bladder carcinom
as, especially those that do not respond to systemic intravesical chem
otherapy. We have tried to mention all significant factors related to
the development of bladder cancer. We conclude that the progress made
in understanding the pathogenesis of bladder cancer has been significa
nt. However, more studies are needed in order to introduce and adopt r
eliable criteria to accurately predict the clinical behavior.